Skip to main content
. 2015 Jun 24;10(7):1027–1036. doi: 10.1097/JTO.0000000000000563

FIGURE 2.

FIGURE 2.

The slow proliferating fraction is appreciable also ex vivo in NSCLC PDX. Cells derived from disaggregation of PDX were PKH labeled and reinjected subcutaneously in SCID mice (n = 4). PKH retaining CD133+ enriched cells are appreciable in tumors analyzed at different volumes (V1 = 250 mm3, V2 = 1000 mm3) in both PDX tested; PDX111 (A) and PDX73 (B).